Soria J - Search Results

1

Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis.

Mirshahi M, Soria C, Soria J, Mirshahi M, Faivre R, Kieffer Y, Bassand JP, Toulemonde F, Caen J. Mirshahi M, et al. Among authors: soria j, soria c. Thromb Res. 1988 Aug 1;51(3):295-302. doi: 10.1016/0049-3848(88)90106-5. Thromb Res. 1988. PMID: 3175985

2

Effect of heparin and enoxaparin on platelet interaction with fibrin clots.

Mirshahi M, Soria J, Neuhart E, Steg PG, Jacob P, Combe S, Soria C. Mirshahi M, et al. Among authors: soria j, soria c. Thromb Res. 1992 Jan 15;65(2):187-91. doi: 10.1016/0049-3848(92)90238-6. Thromb Res. 1992. PMID: 1315989

3

Fibrin degradation products generation and fibrinopeptide A release in normal plasma incubated with thrombolytic agents: proposed mechanisms.

Mirshahi M, Soria J, Bertrand O, Amiral J, Soria C. Mirshahi M, et al. Among authors: soria j, soria c. Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):531-6. doi: 10.1097/00001721-199010000-00032. Blood Coagul Fibrinolysis. 1990. PMID: 1723308

4

Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerization.

Mirshahi M, Soria J, Soria C, Samama M, Caen JP. Mirshahi M, et al. Among authors: soria j, soria c. Thromb Res Suppl. 1990;10:21-6. doi: 10.1016/0049-3848(90)90375-m. Thromb Res Suppl. 1990. PMID: 2107597

5

Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.

Faivre R, Neuhart E, Mirshahi M, Mirshahi M, Soria C, Soria J, Bassand JP, Caen JP, Maurat JP. Faivre R, et al. Among authors: soria j, soria c. Semin Thromb Hemost. 1989 Oct;15(4):435-9. doi: 10.1055/s-2007-1002743. Semin Thromb Hemost. 1989. PMID: 2554504 No abstract available.

6

Glycosylation of human fibrinogen and fibrin in vitro. Its consequences on the properties of fibrin(ogen).

Mirshahi M, Soria J, Soria C, Bertrand O, Mirshahi M, Basdevant A. Mirshahi M, et al. Among authors: soria j, soria c. Thromb Res. 1987 Nov 1;48(3):279-89. doi: 10.1016/0049-3848(87)90440-3. Thromb Res. 1987. PMID: 3124289

7

Defective thrombolysis due to collagen incorporation in fibrin clots.

Mirshahi M, Soria J, Lu H, Soria C, Samama M, Caen JP. Mirshahi M, et al. Among authors: soria j, soria c. Thromb Res Suppl. 1988;8:73-80. doi: 10.1016/0049-3848(88)90156-9. Thromb Res Suppl. 1988. PMID: 3144770

8

Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.

Faivre R, Mirshahi M, Ducellier D, Soria C, Soria J, Mirshahi M, Kieffer Y, Bassand JP, Caen J, Maurat JP. Faivre R, et al. Among authors: soria j, soria c. Thromb Res. 1988 May 15;50(4):583-9. doi: 10.1016/0049-3848(88)90206-x. Thromb Res. 1988. PMID: 3413720 No abstract available.

9

Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation product determination.

Soria C, Soria J, Mirshahi M, Mirshahi M, Dunnica S, Boucheix C, Beaufils R, Slama R, Caen JP. Soria C, et al. Among authors: soria j. Thromb Res. 1987 Feb 15;45(4):383-92. doi: 10.1016/0049-3848(87)90227-1. Thromb Res. 1987. PMID: 3576522

10

A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.

Mirshahi M, Soria J, Soria C, Perrot JY, Boucheix C. Mirshahi M, et al. Among authors: soria j, soria c. Thromb Res. 1986 Dec 15;44(6):715-28. doi: 10.1016/0049-3848(86)90018-6. Thromb Res. 1986. PMID: 3798417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,373 results

Search Page

Filters